VELTASSA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug VELTASSA contains one active pharmaceutical ingredient (API):

1	Patiromer UNII 0LB9J2797D - PATIROMER SORBITEX CALCIUM
	Patiromer is a non-absorbed, cation exchange polymer that contains a calcium-sorbitol complex as a counterion. Patiromer increases faecal potassium excretion through binding of potassium in the lumen of the gastrointestinal tract. Binding of potassium reduces the concentration of free potassium in the gastrointestinal lumen, resulting in a reduction of serum potassium levels.
	Read more about Patiromer

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VELTASSA Powder for oral suspension	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AE09		V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02481359, 02481367
EE	Ravimiamet	1750261, 1750272, 1750283, 1750294, 1750306, 1750317, 1750328, 1750339, 1750340
ES	Centro de información online de medicamentos de la AEMPS	1171179001, 1171179004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	113451, 578950
FR	Base de données publique des médicaments	63705995
GB	Medicines & Healthcare Products Regulatory Agency	347345, 347347
IL	מִשְׂרַד הַבְּרִיאוּת	8313, 9061
IT	Agenzia del Farmaco	045492016, 045492028, 045492030, 045492042, 045492055, 045492067, 045492079, 045492081, 045492093
LT	Valstybinė vaistų kontrolės tarnyba	1083468, 1083469, 1083470, 1083471, 1083472, 1083473, 1083474, 1083475, 1083476
NL	Z-Index G-Standaard, PRK	198463, 198471
PL	Rejestru Produktów Leczniczych	100400251, 100400274, 100400280
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67501001, W67501002, W67501003, W67502001, W67502002, W67502003, W67503001, W67503002, W67503003
US	FDA, National Drug Code	53436-084, 53436-168, 53436-252